Evigrade
Moderate

Cyanocobalamin × Metformin

Vitamins. Haemopoietic stimulants×Biguanides. Oral antihyperglycemic agents

Mechanism

Metformin suppresses calcium-dependent absorption of the B12-intrinsic factor complex in the terminal ileum. With over 4 years of therapy, clinically significant B12 deficiency is reported in 10–30% of patients.

Symptoms

Fatigue, pallor, paraesthesias in hands and feet, gait instability, memory decline. Develops over 2–4 years of unrecognised therapy.

Management

On long-term metformin, check B12 yearly. If it falls below 200 pg/mL, give cyanocobalamin 500–1000 mcg/day orally or 1000 mcg/week intramuscularly (in significant neuropathy). Supplementation does not cancel the metformin indication.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions